Database : MEDLINE
Search on : Apudoma [Words]
References found : 490 [refine]
Displaying: 1 .. 10   in format [Detailed]

page 1 of 49 go to page                         

  1 / 490 MEDLINE  
              next record last record
select
to print
Photocopy

[PMID]: 24641468
[Au] Autor:Alventosa-Mateu C; Ferrer-Barceló L; Huguet-Malavés JM; Ferrer-Arranz L; Monzó-Gallego A; Medina-Chuliá E
[Ti] Title:Zollinger-Ellison syndrome.
[So] Source:Rev Esp Enferm Dig;105(10):641-2, 2013 Nov-Dec.
[Is] ISSN:1130-0108
[Cp] Country of publication:Spain
[La] Language:eng
[Mh] MeSH terms primary: Apudoma/epidemiology
Pancreatic Neoplasms/epidemiology
[Mh] MeSH terms secundary: Female
Humans
Male
[Pt] Publication type:COMMENT; LETTER
[Em] Entry month:1511
[Cu] Class update date: 140319
[Lr] Last revision date:140319
[Js] Journal subset:IM
[Da] Date of entry for processing:140320
[St] Status:MEDLINE

  2 / 490 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 21526871
[Au] Autor:Varas M; Gornals J; Ponseti JM; Alastruè A; Durán C; Llevaria C; Ballesta C; Díez-Caballero A; Artigas V
[Ad] Address:Unit of Digestive Echoendoscopy, Centro Médico Teknon, Barcelona, Spain. varas@dr.teknon.es
[Ti] Title:Pancreatic endocrine tumors or apudomas.
[So] Source:Rev Esp Enferm Dig;103(4):184-90, 2011 Apr.
[Is] ISSN:1130-0108
[Cp] Country of publication:Spain
[La] Language:eng; spa
[Ab] Abstract:INTRODUCTION AND OBJECTIVE: pancreatic endocrine tumors (PET) are difficult to diagnose. Their accurate localization using imaging techniques is intended to provide a definite cure. The goal of this retrospective study was to review a PET series from a private institution. PATIENTS AND METHODS: the medical records of 19 patients with PETs were reviewed, including 4 cases of MEN-1, for a period of 17 years (1994-2010). A database was set up with ten parameters: age, sex, symptoms, imaging techniques, size and location in the pancreas, metastasis, surgery, complications, adjuvant therapies, definite diagnosis, and survival or death. RESULTS: a total of 19 cases were analyzed. Mean age at presentation was 51 years (range: 26-67 y) (14 males, 5 females), and tumor size was 5 to 80 mm (X: 20 mm). Metastatic disease was present in 37% (7/19). Most underwent the following imaging techniques: ultrasounds, computed tomography (CT) an magnetic resonance imaging (MRI). Fine needle aspiration punction (FNA) was performed for the primary tumor in 4 cases. Non-functioning: 7 cases (37%), insulinoma: 2 cases [1 with possible multiple endocrine neoplasia (MEN)], Zollinger-Ellison syndrome (ZES) from gastrinoma: 5 (3 with MEN-1), glucagonoma: 2 cases, 2 somatostatinomas; carcinoid: 1 case with carcinoide-like syndrome. Most patients were operated upon: 14/19 (73%). Four (4/14:28%) has postoperative complications following pancreatectomy: pancreatitis, pseudocyst, and abdominal collections. Some patients received chemotherapy (4), somatostatin (3) and interferon (2) before or after surgery. Median follow-up was 48 months. Actuarial survival during the study was 73.6% (14/19). CONCLUSIONS: age was similar to that described in the literature. Males were predominant. Most cases were non-functioning (37%). Most patients underwent surgery (73%) with little morbidity (28%) and an actuarial survival of 73.6% at the time of the study.
[Mh] MeSH terms primary: Apudoma/epidemiology
Pancreatic Neoplasms/epidemiology
[Mh] MeSH terms secundary: Adult
Aged
Apudoma/diagnosis
Apudoma/pathology
Apudoma/surgery
Databases, Factual
Diagnostic Imaging
Female
Follow-Up Studies
Humans
Male
Middle Aged
Multiple Endocrine Neoplasia Type 1/epidemiology
Pancreatectomy
Pancreatic Neoplasms/diagnosis
Pancreatic Neoplasms/pathology
Pancreatic Neoplasms/surgery
Prognosis
Retrospective Studies
Spain/epidemiology
Survival Rate
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1511
[Cu] Class update date: 110429
[Lr] Last revision date:110429
[Js] Journal subset:IM
[Da] Date of entry for processing:110430
[St] Status:MEDLINE

  3 / 490 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 20583420
[Au] Autor:Krzysztof K; Wiktor B; Tadeusz L; Waldemar B; Magdalena K; Janusz D
[Ad] Address:1st Department of General, Gastrointestinal and Endocrinological Surgery, Silesian Piasts University of Medicine, Wroclaw, Poland. krzysztofkali@wp.pl
[Ti] Title:Neuroendocrine tumours--analysis of own material--a nine--year retrospective study.
[So] Source:Hepatogastroenterology;57(98):236-41, 2010 Mar-Apr.
[Is] ISSN:0172-6390
[Cp] Country of publication:Greece
[La] Language:eng
[Ab] Abstract:BACKGROUND/AIMS: Neuroendocrine tumours are fairly rare neoplasms that require different treatments and have various prognoses. The aim of this study was to present the author's observations of the histological tumor types, occurrence and its surgical treatment. METHODOLOGY: Thirty-five cases of neuroendocrine tumours were studied retrospectively in a 9-year period. All cases were investigated for haematological and biochemical parameters. Ultrasonography, scintigraphy, computed tomography or magnetic resonance imaging of abdominal cavity, pelvis, thorax or neck--depend on the tumor localization--were done in every individual. All cases were subjected to surgical procedure with an aim to resect the tumour completely. RESULTS: In the present study were observed 6 cases of carcinoids localized in ileum, cecum and sigmoid colon, 1 case of gastrinoma in pancreatic head localization, 1 case of insulinoma localized in pancreatic tail, 1 case of vipoma localised in pancreatic head, 2 cases of nesidioblastoma and 1 case of microcystic adenoma with neuroendocrine differentiation in pancreatic tail localization and 1 case of nonspecific apudoma observed in ileum. There were 6 cases of neuroendocrine tumours localized in pancreas. In the study we have also 11 cases of medullary thyroid carcinomas. In adrenal glands we observed 10 benign and 1 malignant pheochromocytoma (one bilateral female case with Multiple Endocrine Neoplasia type 2A). CONCLUSIONS: Neuroendocrine tumours occur very rare. Their clinical course makes recognition difficulties and as a result they are usually quite extensive when first detected. The clinical manifestations of some neuroendocrine tumours are not specific, so it causes a lot of difficulties in early diagnosis and treatment.
[Mh] MeSH terms primary: Gastrointestinal Neoplasms/surgery
Neuroendocrine Tumors/surgery
[Mh] MeSH terms secundary: Diagnostic Imaging
Female
Gastrointestinal Neoplasms/diagnosis
Humans
Male
Middle Aged
Neuroendocrine Tumors/diagnosis
Prognosis
Retrospective Studies
Treatment Outcome
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1008
[Cu] Class update date: 100629
[Lr] Last revision date:100629
[Js] Journal subset:IM
[Da] Date of entry for processing:100630
[St] Status:MEDLINE

  4 / 490 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 20034361
[Au] Autor:Vila JJ; Vicuña M; Irisarri R; de la Higuera BG; Ruiz-Clavijo D; Rodríguez-Gutiérrez C; Urman JM; Bolado F; Jiménez FJ; Arín A
[Ad] Address:Gastroenterology Department, Hospital de Navarra, Pamplona, Spain. juanjvila@gmail.com
[Ti] Title:Diagnostic yield and reliability of endoscopic ultrasonography in patients with idiopathic acute pancreatitis.
[So] Source:Scand J Gastroenterol;45(3):375-81, 2010 Mar.
[Is] ISSN:1502-7708
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:OBJECTIVES: To evaluate the diagnostic yield of endoscopic ultrasonography (EUS) in patients with idiopathic acute pancreatitis (IAP), find factors predictive of a positive EUS finding in these patients and investigate whether these etiological findings are maintained during follow-up. MATERIAL AND METHODS: We performed EUS in patients with IAP between July 2004 and August 2007. We recorded epidemiological data, the number and severity of previous bouts of pancreatitis and gallbladder status. RESULTS: A total of 44 patients were included in the study. EUS was normal in seven patients (16%). In the remaining 37 patients (84%) we found cholelithiasis (n = 3), microlithiasis (n = 20), chronic pancreatitis (n = 14), pancreas divisum (n = 3), pancreatic mass (n = 1), apudoma (n = 1), cystic tumor of the pancreas (n = 2) and choledocholithiasis (n = 2). Positive EUS findings were not influenced by sex, severity of pancreatitis or recurrent disease. Patients aged < 65 years (age > or < 65 years: 73.9% versus 95.2%; P = 0.097) and patients with gallbladder in situ (cholecystectomy versus non-cholecystectomy: 63.6% versus 90.9%; P = 0.054) showed a tendency to have positive EUS findings. Mean follow-up was 28.95 +/- 10.86 months (range 12-64 months; median 28 months). During follow-up the etiological diagnosis was changed in two patients, lowering the diagnostic yield to 79%. CONCLUSIONS: EUS identified the cause of IAP in 79% of patients. Patients with gallbladder in situ and patients aged < 65 years showed a tendency to have positive EUS findings. The majority of the diagnoses provided by EUS are maintained during follow-up and seem to be reliable.
[Mh] MeSH terms primary: Endosonography
Pancreatitis/diagnostic imaging
Pancreatitis/etiology
[Mh] MeSH terms secundary: Adult
Aged
Aged, 80 and over
Female
Humans
Male
Middle Aged
Predictive Value of Tests
Reproducibility of Results
Severity of Illness Index
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1007
[Cu] Class update date: 161125
[Lr] Last revision date:161125
[Js] Journal subset:IM
[Da] Date of entry for processing:091226
[St] Status:MEDLINE
[do] DOI:10.3109/00365520903508894

  5 / 490 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 18401203
[Au] Autor:Faggiano A; Mansueto G; Ferolla P; Milone F; del Basso de Caro ML; Lombardi G; Colao A; De Rosa G
[Ad] Address:Department of Molecular and Clinical Endocrinology and Oncology, Federico II University of Naples, 80131, Naples, Italy. afaggian@unina.it
[Ti] Title:Diagnostic and prognostic implications of the World Health Organization classification of neuroendocrine tumors.
[So] Source:J Endocrinol Invest;31(3):216-23, 2008 Mar.
[Is] ISSN:1720-8386
[Cp] Country of publication:Italy
[La] Language:eng
[Ab] Abstract:BACKGROUND: Neuroendocrine differentiation of tumors is often difficult to establish. In the same manner, the evaluation of the prognostic role of neuroendocrine differentiation may constitute a relevant clinical problem. Although different classifications are used for neuroendocrine tumors (NET) of different origin, the last World Health Organization (WHO) classification of NET, originally proposed for gastroenteropancreatic tumors, has proved to be a practical tool to allow pathologists to uniform the diagnoses and re-classify these tumors into 3 main categories. AIM: The present study was carried out in order to evaluate diagnostic and prognostic implications of NET reclassification according to the last WHO classification of NET. MATERIALS AND METHODS: Thirty-one tumors with an initial diagnosis referable to a NET achieved before 1999 were independently evaluated by 3 pathologists on the basis of the 2000 WHO classification of NET. Immunohistochemistry for panneuroendocrine markers and Ki-67 was also performed in all cases. RESULTS: Twelve, 14, and 4 tumors were respectively reclassified as well-differentiated NET, well-differentiated neuroendocrine carcinoma and poorly differentiated neuroendocrine carcinoma; 1 tumor was reclassified as mixed endocrine-exocrine tumor. Two or more neuroendocrine markers were expressed in all NET regardless of histotype, differentiation degree, and site of primary tumor. After revision, 10 of the 31 tumors under study (32%) changed histo-prognostic category when compared to the initial diagnosis. Ki-67 score was the best predictor of survival at the multivariate analysis. CONCLUSION: The WHO classification is suitable to accurately reclassify tumors with an initial diagnosis referable to a NET and to separate these tumors in 3 well-distinct histo-prognostic categories with relevant clinical implications. Ki-67 score seems to be a better predictor of survival than the degree of differentiation.
[Mh] MeSH terms primary: Neuroendocrine Tumors/classification
Neuroendocrine Tumors/diagnosis
World Health Organization
[Mh] MeSH terms secundary: Analysis of Variance
Apudoma/classification
Apudoma/diagnosis
Carcinoid Tumor/classification
Carcinoid Tumor/diagnosis
Carcinoma, Neuroendocrine/classification
Carcinoma, Neuroendocrine/diagnosis
Cell Differentiation
Gastrinoma/classification
Gastrinoma/diagnosis
Humans
Immunohistochemistry
Insulinoma/classification
Insulinoma/diagnosis
Ki-67 Antigen/analysis
Neuroendocrine Tumors/mortality
Prognosis
[Pt] Publication type:JOURNAL ARTICLE
[Nm] Name of substance:0 (Ki-67 Antigen)
[Em] Entry month:0805
[Cu] Class update date: 171114
[Lr] Last revision date:171114
[Js] Journal subset:IM
[Da] Date of entry for processing:080411
[St] Status:MEDLINE

  6 / 490 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 18355359
[Au] Autor:Cheng S; Edmonds E; Ben-Gashir M; Yu RC
[Ad] Address:Departments of Dermatology and Histopathology, University College London Hospital, London, UK. suzanne.cheng@gmail.com
[Ti] Title:Subcorneal pustular dermatosis: 50 years on.
[So] Source:Clin Exp Dermatol;33(3):229-33, 2008 May.
[Is] ISSN:0307-6938
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:We review the key developments in our understanding of subcorneal pustular dermatosis (SCPD, also known as Sneddon-Wilkinson disease) over the past 50 years. SCPD is a rare, chronic, sterile pustular eruption that was first described by Sneddon and Wilkinson in 1956. The primary lesions are pea-sized pustules classically described as half-pustular, half-clear flaccid fluid blisters. Histologically the salient feature is a subcorneal accumulation of neutrophils, suggesting the presence of chemoattractants such as tumour necrosis factor (TNF)alpha in the uppermost epidermis. However, to date its exact pathophysiology is unknown. Cases in association with pyoderma gangrenosum, benign monoclonal IgA gammopathy and multiple myeloma are well documented. There are anecdotal reports of SCPD associated with other internal malignancies such as chronic lymphocytic leukaemia, thymoma, apudoma and epidermoid carcinoma of the lung. The treatment of choice is dapsone. Therapeutic alternatives include retinoids, phototreatment with psoralen ultraviolet (UV) A, broadband or narrow band UVB and corticosteroids. Anecdotal uses of tacalcitol, ketoconazole, azithromycin, tetracycline, minocycline, vitamin E, ciclosporin, colchicine, mizoribine, mebhydrolin, infliximab and adalimumab with mycophenolate mofetil have all been reported.
[Mh] MeSH terms primary: Immunoglobulin A
Pyoderma Gangrenosum
Skin Diseases, Vesiculobullous
[Mh] MeSH terms secundary: Anti-Inflammatory Agents, Non-Steroidal/therapeutic use
Blister/etiology
Dapsone/therapeutic use
Diagnosis, Differential
Female
Humans
Immunoglobulin A/metabolism
Male
Paraproteinemias/diagnosis
Pyoderma Gangrenosum/drug therapy
Pyoderma Gangrenosum/pathology
Skin Diseases, Vesiculobullous/drug therapy
Skin Diseases, Vesiculobullous/pathology
Treatment Outcome
[Pt] Publication type:JOURNAL ARTICLE; REVIEW
[Nm] Name of substance:0 (Anti-Inflammatory Agents, Non-Steroidal); 0 (Immunoglobulin A); 8W5C518302 (Dapsone)
[Em] Entry month:0808
[Cu] Class update date: 131121
[Lr] Last revision date:131121
[Js] Journal subset:IM
[Da] Date of entry for processing:080322
[St] Status:MEDLINE
[do] DOI:10.1111/j.1365-2230.2008.02706.x

  7 / 490 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 17022568
[Au] Autor:Imai Y; Ohmura E
[Ad] Address:Department of Endocrinology and Diabetes, Saitama Medical Center, Saitama University.
[Ti] Title:[Paraneuroma (APUDoma)].
[So] Source:Nihon Rinsho;Suppl 3:375-8, 2006 Sep 28.
[Is] ISSN:0047-1852
[Cp] Country of publication:Japan
[La] Language:jpn
[Mh] MeSH terms primary: Apudoma
[Mh] MeSH terms secundary: Apudoma/diagnosis
Apudoma/physiopathology
Apudoma/secretion
Apudoma/therapy
Humans
Isotopes/therapeutic use
Octreotide
Peptide Hormones/secretion
Serotonin/secretion
Somatostatin/therapeutic use
Surgical Procedures, Operative
[Pt] Publication type:JOURNAL ARTICLE; REVIEW
[Nm] Name of substance:0 (Isotopes); 0 (Peptide Hormones); 333DO1RDJY (Serotonin); 51110-01-1 (Somatostatin); RWM8CCW8GP (Octreotide)
[Em] Entry month:0701
[Cu] Class update date: 131121
[Lr] Last revision date:131121
[Js] Journal subset:IM
[Da] Date of entry for processing:061007
[St] Status:MEDLINE

  8 / 490 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 16785371
[Au] Autor:Lewis KG; Weinstock MA; Weaver AL; Otley CC
[Ad] Address:Department of Dermatology, Brown Medical School, and Dermatoepidemiology Unit, Veterans Affairs Medical Center, Providence, RI, USA.
[Ti] Title:Adjuvant local irradiation for Merkel cell carcinoma.
[So] Source:Arch Dermatol;142(6):693-700, 2006 Jun.
[Is] ISSN:0003-987X
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:OBJECTIVES: To determine the effect of adjuvant local irradiation on (1) disease recurrence and (2) survival rates in Merkel cell carcinoma (MCC). DATA SOURCES: An Ovid MEDLINE search (January 1966-May 26, 2004) was performed using the following criteria: group 1, "Merkel cell OR trabecular OR neuroendocrine skin OR APUDoma skin OR primary small cell skin OR primary undifferentiated skin OR endocrine skin OR neuroepithelial" AND group 2, "carcinoma OR tumor OR cancer" with mapping modifiers "-title, -abstract, -keyword, -subject heading." The search yielded 843 citations. STUDY SELECTION: The Ovid set was then searched using the following criteria: "surgery OR radiation OR radiotherapy," which yielded 242 discrete citations. Reports from all 242 citations were reviewed. For the remaining 601 citations, abstracts (when available) were reviewed to assess the level of relevance for potential inclusion; reports from 63 of these citations were reviewed. An additional 28 secondary references were reviewed, for a total of 333 reports. DATA EXTRACTION: The following criteria for inclusion were applied to each potential patient: (1) a histopathologic diagnosis of MCC; (2) a single, primary tumor arising on the skin, for which (3) the primary treatment was surgical excision (local excision, wide excision, or Mohs surgery) with or without the use of adjuvant irradiation (to the tumor bed); (4) following surgery, negative (clear) surgical margins were obtained; (5) during the postoperative follow-up period, disease recurrence, progression, and survival and/or duration of event-free interval was documented with (6) a minimum follow-up of 1 month. A total of 1254 patients were included in the analysis. RESULTS: Statistically significant reductions in local (hazard ratio [HR], 0.27; P < .001) and regional (HR, 0.34; P < .001) recurrence were observed among patients treated with combination therapy compared with surgery alone. Similar rates of distant metastasis were observed between treatment groups (HR, 0.79; P = .31). Overall survival rates were 87% (1 year) and 49% (5 years). Cause-specific survival rates were 90% (1 year) and 62% (5 year). In general, differences in overall (HR, 0.78; P = .16) and cause-specific (due to MCC: HR, 0.72; P = .14) survival rates between treatment groups did not reach statistical significance. A subgroup analysis that excluded single-patient case reports and studies of only 1 treatment group revealed a significant overall (HR, 0.63; P = .02) and cause-specific (HR, 0.62; P = .04) survival advantage after treatment with combination therapy. CONCLUSIONS: Surgery plus local adjuvant irradiation was associated with significantly lower rates of local and regional recurrence of MCC than surgery alone. Prospective investigation is needed to clarify the presence of a survival benefit from combination therapy.
[Mh] MeSH terms primary: Carcinoma, Merkel Cell/radiotherapy
Neoplasm Recurrence, Local/radiotherapy
Skin Neoplasms/radiotherapy
[Mh] MeSH terms secundary: Adult
Aged
Aged, 80 and over
Carcinoma, Merkel Cell/mortality
Carcinoma, Merkel Cell/pathology
Carcinoma, Merkel Cell/surgery
Combined Modality Therapy
Female
Humans
Male
Middle Aged
Neoplasm Metastasis
Neoplasm Recurrence, Local/mortality
Neoplasm Recurrence, Local/pathology
Neoplasm Recurrence, Local/surgery
Neoplasm Staging
Radiotherapy, Adjuvant
Skin Neoplasms/mortality
Skin Neoplasms/pathology
Skin Neoplasms/surgery
Survival Analysis
[Pt] Publication type:JOURNAL ARTICLE; META-ANALYSIS
[Em] Entry month:0607
[Cu] Class update date: 080317
[Lr] Last revision date:080317
[Js] Journal subset:AIM; IM
[Da] Date of entry for processing:060621
[St] Status:MEDLINE

  9 / 490 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 12560757
[Au] Autor:Amarapurkar AD; Davies A; Ramage JK; Stangou AJ; Wight DG; Portmann BC
[Ad] Address:Institute of Liver Studies and Carcinoid Clinic, King's College Hospital, Denmark Hill, London SE5 9RS, UK.
[Ti] Title:Proliferation of antigen MIB-1 in metastatic carcinoid tumours removed at liver transplantation: relevance to prognosis.
[So] Source:Eur J Gastroenterol Hepatol;15(2):139-43, 2003 Feb.
[Is] ISSN:0954-691X
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:BACKGROUND: Metastatic carcinoid tumours are difficult to manage. In spite of a multidisciplinary approach, including orthotopic liver transplantation, the recurrence rate is high with a poor prognosis. Histopathology generally fails to provide prognostic information, hence it is essential to try to identify markers of prognosis in these tumours before considering orthotopic liver transplantation. The MIB-1 antibody, which detects cell proliferative activity, has been shown to be a useful prognostic marker for a variety of neoplasms. AIMS: To assess the value of MIB-1 immunostaining as a prognostic marker of the duration to recurrence and the survival of patients undergoing orthotopic liver transplantation for metastatic carcinoid/neuroendocrine tumours of the liver. METHODS: Fourteen patients were included in the study. Formalin-fixed, paraffin-embedded tissue sections of the tumours were stained with routine haematoxylin and eosin and chromogranin. The cell proliferative activity was assessed by MIB-1 antibody labelling using the immunoperoxidase method. Results were correlated with the time of tumour recurrence and the length of patients' survival after transplantation. RESULTS: No correlation was found between MIB-1 labelling index and age, gender, clinical and histological type of tumour (i.e. carcinoid, APUDOMA, secreting or non-secreting). The patients with higher MIB-1 indices ( 5%) showed a trend toward earlier recurrence and poorer survival than those with low MIB-1 indices ( 5%). The predictive value of a MIB-1 index of 2 indicating patient survival of 24 months was 83% (five out of six patients). CONCLUSIONS: The correlation between MIB-1 index and patients' survival suggests that a high proliferative rate, as assessed by MIB-1 immunostaining, may detect those tumours with more aggressive biological behaviour. Prospective studies on a larger number of patients will be needed to determine if, in any individual tumour, this method will provide an additional parameter for a rational approach to therapy.
[Mh] MeSH terms primary: Antigens, Neoplasm/analysis
Apudoma/immunology
Carcinoid Tumor/immunology
Gastrointestinal Neoplasms/pathology
Ki-67 Antigen/analysis
Liver Neoplasms/immunology
[Mh] MeSH terms secundary: Adult
Apudoma/secondary
Apudoma/surgery
Carcinoid Tumor/secondary
Carcinoid Tumor/surgery
Cell Division
Female
Gastrointestinal Neoplasms/immunology
Humans
Liver Neoplasms/secondary
Liver Neoplasms/surgery
Liver Transplantation
Male
Middle Aged
Neoplasm Recurrence, Local/diagnosis
Neoplasm Recurrence, Local/immunology
Predictive Value of Tests
Prognosis
Time Factors
[Pt] Publication type:JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T
[Nm] Name of substance:0 (Antigens, Neoplasm); 0 (Ki-67 Antigen)
[Em] Entry month:0305
[Cu] Class update date: 091016
[Lr] Last revision date:091016
[Js] Journal subset:IM
[Da] Date of entry for processing:030201
[St] Status:MEDLINE

  10 / 490 MEDLINE  
              first record previous record
select
to print
Photocopy

[PMID]: 12109233
[Au] Autor:Galati G; Fiori E; Tiziano G; Sammartino F; De Cesare A; Bononi M; Barbarosos A; Bolognese A
[Ad] Address:Dipartimento di Chirurgia Pietro Valdoni, Università degli Studi La Sapienza, Roma.
[Ti] Title:Apudoma dell'ampolla di Vater: caso clinico e revisione della letteratura. [Apudoma of Vater's ampulla: case report and review of the literature].
[So] Source:G Chir;23(3):97-100, 2002 Mar.
[Is] ISSN:0391-9005
[Cp] Country of publication:Italy
[La] Language:ita
[Ab] Abstract:The Authors report a case of Vater's ampulla apudoma and after having examined the characteristics of these neoplasms they discuss clinical presentation, diagnostic and treatment problems of islet cell adenomas. They review the literature and make some remarks.
[Mh] MeSH terms primary: Ampulla of Vater
Apudoma
Common Bile Duct Neoplasms
[Mh] MeSH terms secundary: Aged
Apudoma/diagnosis
Apudoma/therapy
Common Bile Duct Neoplasms/diagnosis
Common Bile Duct Neoplasms/therapy
Female
Humans
[Pt] Publication type:CASE REPORTS; ENGLISH ABSTRACT; JOURNAL ARTICLE; REVIEW
[Em] Entry month:0209
[Cu] Class update date: 061115
[Lr] Last revision date:061115
[Js] Journal subset:IM
[Da] Date of entry for processing:020712
[St] Status:MEDLINE


page 1 of 49 go to page                         
   


Refine the search
  Database : MEDLINE Advanced form   

    Search in field  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information